Ashley Capoot’s Post

Gallagher's Seth Friedman spoke to CNBC about the availability of drugs like Ozempic through employee healthcare plans. Drugs like Ozempic are cost drivers to the plan and understanding what coverage looks like across health plans is key to managing cost and access for patients. Read the full article here: https://lnkd.in/gkFZhxs3

Gallagher's Seth Friedman spoke to CNBC about the availability of drugs like Ozempic through employee healthcare plans. Drugs like Ozempic are cost drivers to the plan and understanding what coverage looks like across health plans is key to managing cost and access for patients. Read the full article here: https://lnkd.in/gcWJxAmV

The demand for weight loss drugs is high but so is the cost and commitment! With soaring health care and drug costs employers are faced with difficult decisions for 2025! The spend for these patent weight loss drugs is extreme! Employers may see the benefits and want to cover them but financially cannot.

Digital health companies are launching programs around GLP-1 medications for diabetes and obesity management. These programs aim to improve patient adherence and outcomes through digital monitoring and support. By integrating GLP-1 treatments with digital health tools, companies hope to offer more effective and personalised care. This trend highlights the growing synergy between pharmaceuticals and digital health, promising advancements in chronic disease management. What would you add? Found this useful? Repost ♻️ to help your network. Join a community of 85,712+ HealthTech leaders finding the ideas, people, innovations and technologies that are shaping the future of healthcare. 👉 http://lnkd.in/eExMcaG6

Biomarker bills are merely the latest in what is likely to be a wave of legislation mandating coverage of new tests and therapies that are part of the growth in precision medicine. This will make it increasingly difficult for plans to control costs and premiums while meeting mandates. Alex Sommer offers insights into what payers must consider to adopt a flexible and scalable solution for health plans. #FirstReportManagedCare #Biomarkers #BiomarkerLegislation #Payers

Reports are coming out stating 2025 Marketplace insurance premium increases will rise ~7% on average. Likely to be similar on the self-insured and fully-insured side, if not worse. Isn't time to think differently about how your enterprise can approach this differently and much more effectively? It can be done and it can be done scientifically, with a plan, and with proven return on your investment. Creating a culture of health, safety & well-being where your employees and their families can thrive is complicated, takes time, but most importantly, deserves a plan of action that takes that guesswork out. HealthNEXT has nearly two decades of published research supporting our best practices. We build effective strategic plans for you and your organization to achieve benchmark cultures of Health, Safety & Well-Being. Let HealthNEXT help you take the guesswork out! https://lnkd.in/eyzntrtF https://lnkd.in/exgqfJgH #healthnext, #cultureofhealth, #wellness, #wellbeing

These reports are finally calling it out. Do you know who is managing the cost of medications that your employees are taking? As a plan fiduciary you should take a deeper dive, we can show you how to remove this egregious waste in your health plan.

How digital health companies are capitalizing on the GLP-1 boom In addition to Wegovy and Ozempic, the GLP-1 class includes Eli Lilly’s highly popular weight loss drug Zepbound and diabetes treatment Mounjaro. GLP-1s mimic a hormone produced in the gut to suppress a person’s appetite and regulate blood sugar. Like Ro, other non-drugmakers, including Calibrate, Sesame, Omada Health, Noom, Hims & Hers and even telehealth industry veterans Teladoc Health and WeightWatchers, have rolled out offerings geared toward patients on GLP-1s, or have expanded their services to include the popular medications. https://lnkd.in/epxjueBN

As the Commonwealth explores ways to mitigate the uncertainty surrounding Steward Health Care's financial challenges and the potential impact on the hospital, health system, and provider landscape, our latest OnPoint offers sound recommendations for preserving access for patients to high-quality and affordable health care. Read more about the statutory and regulatory oversight structures in place today for health plans, hospitals, health systems, and the pharmaceutical industry and recommendations for enhancing oversight to ensure stability in our health care ecosystem. https://lnkd.in/evNiq_Ny

A transparent pharmacy benefit manager (PBM) is one that provides clear and detailed information about its operations, pricing, and contracts with pharmacies and health plans. Transparent PBMs aim to minimize hidden fees and conflicts of interest, offering greater visibility into drug pricing and rebates to their clients, such as health insurers or employers. #TransparentPBM (TransparentPBM.com) is available! #PBM #healthcare #XelaDomains